A similar mechanism has been observed in diabetic retinopathy, where decreased MEG3 expression facilitates endothelial-mesenchymal transition (endMT) via the PI3K/Akt/mTOR signaling pathway [54], potentially implicating its role in RB as well. The gene discussed is MEG3; the disease is retinoblastoma.